Literature DB >> 16226828

Molecularly imprinted polymers in the drug discovery process.

Daniel L Rathbone1.   

Abstract

Since molecularly imprinted polymers (MIPs) are designed to have a memory for their molecular templates it is easy to draw parallels with the affinity between biological receptors and their substrates. Could MIPs take the place of natural receptors in the selection of potential drug molecules from synthetic compound libraries? To answer that question this review discusses the results of MIP studies which attempt to emulate natural receptors. In addition the possible use of MIPs to guide a compound library synthesis towards a desired biological activity is highlighted.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16226828     DOI: 10.1016/j.addr.2005.07.017

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  4 in total

1.  Isolation of hypoxia-inducible factor 1 (HIF-1) inhibitors from frankincense using a molecularly imprinted polymer.

Authors:  Achillia Lakka; Ilias Mylonis; Sophia Bonanou; George Simos; Andreas Tsakalof
Journal:  Invest New Drugs       Date:  2010-05-01       Impact factor: 3.850

2.  A non-biological method for screening active components against influenza virus from traditional Chinese medicine by coupling a LC column with oseltamivir molecularly imprinted polymers.

Authors:  Ya-Jun Yang; Jian-Yong Li; Xi-Wang Liu; Ji-Yu Zhang; Yu-Rong Liu; Bing Li
Journal:  PLoS One       Date:  2013-12-26       Impact factor: 3.240

3.  Preparation and Evaluation of Oseltamivir Molecularly Imprinted Polymer Silica Gel as Liquid Chromatography Stationary Phase.

Authors:  Ya-Jun Yang; Xi-Wang Liu; Xiao-Jun Kong; Zhe Qin; Zeng-Hua Jiao; Shi-Hong Li; Jian-Yong Li
Journal:  Molecules       Date:  2018-07-27       Impact factor: 4.411

4.  New concepts and approaches for drug discovery based on traditional Chinese medicine.

Authors:  Xiaojie Xu
Journal:  Drug Discov Today Technol       Date:  2006
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.